Guillain-Barré syndrome after exposure to influenza virus
- PMID: 20797646
- DOI: 10.1016/S1473-3099(10)70140-7
Guillain-Barré syndrome after exposure to influenza virus
Abstract
Guillain-Barré syndrome (GBS) is an acute, acquired, monophasic autoimmune disorder of peripheral nerves that develops in susceptible individuals after infection and, in rare cases, after immunisation. Exposure to influenza via infection or vaccination has been associated with GBS. We review the relation between GBS and these routes of exposure. Epidemiological studies have shown that, except for the 1976 US national immunisation programme against swine-origin influenza A H1N1 subtype A/NJ/76, influenza vaccine has probably not caused GBS or, if it has, rates have been extremely low (less than one case per million vaccine recipients). By contrast, influenza-like illnesses seem to be relevant triggering events for GBS. The concerns about the risk of inducing GBS in mass immunisation programmes against H1N1 2009 do not, therefore, seem justified by the available epidemiological data. However, the experiences from the 1976 swine flu vaccination programme emphasise the importance for active and passive surveillance to monitor vaccine safety.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Comment in
-
[Guillain-Barré syndrome and the influenza virus].Rev Chilena Infectol. 2010 Dec;27(6):570-1. doi: 10.4067/s0716-10182010000700015. Rev Chilena Infectol. 2010. PMID: 21290888 Spanish. No abstract available.
Similar articles
-
Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.MMWR Morb Mortal Wkly Rep. 2010 Jun 4;59(21):657-61. MMWR Morb Mortal Wkly Rep. 2010. PMID: 20520590
-
Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.Am J Epidemiol. 2013 Sep 15;178(6):962-73. doi: 10.1093/aje/kwt051. Epub 2013 May 6. Am J Epidemiol. 2013. PMID: 23652165
-
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13. Lancet. 2013. PMID: 23498095
-
Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9. Clin Infect Dis. 2014. PMID: 24415636 Review.
-
[Guillain-Barré syndrome after exposure to influenza].Nervenarzt. 2012 Jun;83(6):714-30. doi: 10.1007/s00115-012-3479-8. Nervenarzt. 2012. PMID: 22528062 Review. German.
Cited by
-
Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes.Br J Clin Pharmacol. 2012 May;73(5):801-11. doi: 10.1111/j.1365-2125.2011.04142.x. Br J Clin Pharmacol. 2012. PMID: 22082196 Free PMC article.
-
Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988-2010.Emerg Infect Dis. 2012 Feb;18(2):226-33. doi: 10.3201/eid1802.111126. Emerg Infect Dis. 2012. PMID: 22304786 Free PMC article.
-
Guillain-Barré syndrome following influenza vaccination: A 15-year nationwide population-based case-control study.Eur J Neurol. 2022 Nov;29(11):3389-3394. doi: 10.1111/ene.15516. Epub 2022 Aug 13. Eur J Neurol. 2022. PMID: 35913431 Free PMC article.
-
Disability evaluation in patients with Guillain-Barre syndrome and SARS-CoV-2 infection.Front Neurol. 2023 Jun 29;14:1191520. doi: 10.3389/fneur.2023.1191520. eCollection 2023. Front Neurol. 2023. PMID: 37483451 Free PMC article.
-
Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.BMC Public Health. 2011 May 17;11:329. doi: 10.1186/1471-2458-11-329. BMC Public Health. 2011. PMID: 21586163 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical